// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Incidental finding of endometrial cancer: results from a multicentre prospective cohort study (IETA3)†

R. Heremans - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Endometrial Cancer

N/A

A machine‐learning algorithm to distinguish benign and malignant adnexal tumours from ultrasound images

D. Al-Karawi - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fluvastatin

Management of adnexal masses during pregnancy: a prospective study

C. Landolfo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Movement of the fetal head during active pushing assessed with ultrasound

B.H. Kahrs - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ultrasound in the second stage of labour before instrumental vaginal delivery: a randomised controlled trial

J.G. Barros - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Trauma

N/A

Role of prenatal magnetic resonance imaging in fetuses with isolated ventriculomegaly: a multicentre study*

D. Di Mascio - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hydrocephalus, congenital, 1

Methadone hydrochloride

Prevalence of malignancy or premalignancy in postmenopausal women without vaginal bleeding in whom the endometrial thickness measured ≥11mm*

M. Wong - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tamoxifen

Incidental finding of endometrial polyps: results from a prospective multicentre study (IETA3)*

R. Heremans - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Low Papp‐A at booking: is serial ultrasound surveillance warranted?

A. Anness - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Value of universal third trimester ultrasonography as predictor of adverse perinatal outcome at term

A. Cavallaro - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Suloctidil

Bioeffects safety indices of ultrasound: quantifying adherence to recommendations on routine obstetric scan

L. Drukker - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Introducing ISUOG's Basic Training novel approach to the second trimester anomaly scan: the 20+2 planes

T. Chudleigh - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Role of early ultrasound scan: a two‐year study of cases of increased nuchal translucency with normal karyotype

M.M. Elsayed - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Syndromic craniofacial dysmorphic feature assessment in utero: potential for a novel imaging methodology with reconstructed 3D fetal MRI models

J. Matthew - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management of borderline ovarian tumours: overall survival and long‐term follow‐up

S. Saso - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The effect of flow and oxygenation on cortical development in fetuses with congenital heart defects using an automated brain‐maturation prediction algorithm

S.M. Everwijn - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identification of intrapartum fetal compromise using universal third trimester ultrasonography

P. Iannone - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of human chorionic gonadotrophin and transvaginal ultrasound in pregnancies of unknown location beyond 48 hours

C. Kyriacou - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

N/A

Implementation of a tool for predicting early pregnancy outcome: a psychological impact study

K. Lawson - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

External validation of the M6 model and the two‐step triage system for pregnancies of unknown location

E. Christodoulou - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved